These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 741458)

  • 1. The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivo.
    Buchanan MR; Rosenfeld J; Hirsh J
    Thromb Res; 1978 Nov; 13(5):883-92. PubMed ID: 741458
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of acetylsalicylic acid, sulfinpyrazone and their combination on collagen-induced platelet aggregation in guinea pigs.
    Wong LT; Zawidzka Z; Thomas BH
    Pharmacol Res Commun; 1978 Nov; 10(10):939-49. PubMed ID: 733865
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of sulfinpyrazone on enhanced platelet aggregation in vitro (author's transl)].
    Walter E; Weber E
    Arzneimittelforschung; 1978; 28(10):1778-81. PubMed ID: 582683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between inhibitory effect on platelet aggregation and disposition of sulfinpyrazone and its metabolites in rabbits. Part I: Single dose study.
    Ritschel WA; Kuo BS
    Biopharm Drug Dispos; 1987; 8(1):1-9. PubMed ID: 3107626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between inhibitory effect on platelet aggregation and disposition of sulfinpyrazone and its metabolites in rabbits. Part II: Multiple dose study.
    Kuo BS; Ritschel WA
    Biopharm Drug Dispos; 1987; 8(1):11-21. PubMed ID: 3580509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sulphinpyrazone on the aggregation and release reactions of human platelets.
    Wiley JS; Chesterman CN; Morgan FJ; Castaldi PA
    Thromb Res; 1979 Jan; 14(1):23-33. PubMed ID: 570742
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
    Lorenz R; Siess W; Weber PC
    Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of antithrombotic drugs ex vivo and in vivo.
    Buchanan M; Hirsh J
    Bibl Anat; 1977; (16 Pt 2):208-11. PubMed ID: 603518
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of orally administered sulphinpyrazone (Anturan) on platelet aggregation in vitro.
    Pfister B; Godbillon J; Colussi D; Imhof P
    Thromb Res; 1980 Apr 1-15; 18(1-2):89-99. PubMed ID: 7404507
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing.
    Pedersen AK; FitzGerald GA
    Clin Pharmacol Ther; 1985 Jan; 37(1):36-42. PubMed ID: 3917387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE; Bergqvist D; Tangen O
    Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A metabolite of sulphinpyrazone that is largely responsible for the effect of the drug on the platelet prostaglandin pathway.
    Pay GF; Wallis RB; Zelaschi D
    Biochem Soc Trans; 1980 Dec; 8(6):727-8. PubMed ID: 7461266
    [No Abstract]   [Full Text] [Related]  

  • 13. Two new metabolites of sulfinpyrazone in the rabbit: a possible cause of the prolonged in vivo effect.
    Pedersen AK; Jakobsen P
    Thromb Res; 1979; 16(5-6):871-6. PubMed ID: 524326
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of sulphinpyrazone on human platelet aggregation, 5-hydroxytryptamine release and adhesion ex vivo: comparison with naproxen.
    Nunn B; James FJ
    Br J Clin Pharmacol; 1980 Mar; 9(3):239-45. PubMed ID: 7362733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the relationship between ex vivo and in vivo effects of sulphinpyrazone in the guinea pig.
    Butler KD; Wallis RB; White AM
    Haemostasis; 1979; 8(3-5):353-60. PubMed ID: 159853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of platelet aggregation by platelet inhibitory agents and its relation to their clinical effects].
    Yasunaga K
    Rinsho Byori; 1979; Suppl 40():181-7. PubMed ID: 551223
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged inhibition of ex vivo sodium arachidonate-induced platelet aggregation and malondialdehyde (MDA) production by sulphinpyrazone (Anturan) in man.
    Maguire ED; Pay GF; Wallis RB; White AM
    Thromb Res; 1981 Feb; 21(3):321-7. PubMed ID: 7245142
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of heparin, sulfinpyrazone and acetylsalicylic acid on the collagen-induced thromboyte aggregation].
    Haas S; Fritsche HM; Ketterl R; Leimgruber D; Blümel G
    Med Welt; 1979 Jun; 30(22):862-7. PubMed ID: 440074
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of platelet adhesion to rabbit aorta by sulphinpyrazone and acetylsalicylic acid.
    Essien EM; Mustard JF
    Atherosclerosis; 1977 May; 27(1):89-95. PubMed ID: 856231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
    Baumgartner HR
    Haemostasis; 1979; 8(3-5):340-52. PubMed ID: 511014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.